Related Experiment Videos

Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha

R C Newton¹, C P Decicco

¹Departments of Inflammatory Diseases Research and Chemical and Physical Sciences, The DuPont Pharmaceuticals Company, Experimental Station, P.O. Box 80500, Wilmington, Delaware 19880-0500, USA.

Journal of Medicinal Chemistry

|July 8, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.

International journal of obesity (2005)·2015

Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy.

Current cancer drug targets·2009

Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve.

Lymphology·2006

Biology of TACE inhibition.

Annals of the rheumatic diseases·2002

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.

Proceedings of the National Academy of Sciences of the United States of America·2001

Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.

Journal of medicinal chemistry·2001

See all related articles